A Phase IIa Study of Safety and Efficacy of NOX-100 for Preventing Hypotension in Patients During Hemodialysis Sessions
This study is designed to evaluate the safety, tolerability and efficacy profile of NOX-100 to reduce intradialytic hypotension (IDH) in patients undergoing chronic hemodialysis (HD).
100 项与 Medinox, Inc. 相关的临床结果
0 项与 Medinox, Inc. 相关的专利(医药)
100 项与 Medinox, Inc. 相关的药物交易
100 项与 Medinox, Inc. 相关的转化医学